Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Non Operating Income: 2009-2024

Historic Non Operating Income for Tg Therapeutics (TGTX) over the last 16 years, with Dec 2024 value amounting to -$16.3 million.

  • Tg Therapeutics' Non Operating Income rose 57.68% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.3 million, marking a year-over-year increase of 38.18%. This contributed to the annual value of -$16.3 million for FY2024, which is 115.76% down from last year.
  • Tg Therapeutics' Non Operating Income amounted to -$16.3 million in FY2024, which was down 115.76% from -$7.6 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Non Operating Income ranged from a high of -$3.3 million in FY2021 and a low of -$16.3 million during FY2024.
  • For the 3-year period, Tg Therapeutics' Non Operating Income averaged around -$9.8 million, with its median value being -$7.6 million (2023).
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 42.44% in 2021, then plummeted by 115.76% in 2024.
  • Over the past 5 years, Tg Therapeutics' Non Operating Income (Yearly) stood at -$5.8 million in 2020, then soared by 42.44% to -$3.3 million in 2021, then tumbled by 65.00% to -$5.5 million in 2022, then crashed by 37.75% to -$7.6 million in 2023, then crashed by 115.76% to -$16.3 million in 2024.